Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Vertex Pharmaceuticals Inc.
DescriptionP38 mitogen-activated protein kinase (p38 MAPK) inhibitor
Molecular Target p38 mitogen-activated protein kinase (p38 MAPK) (MAPK14)
Mechanism of ActionMAP kinase (p38) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation
PartnerEIP Pharma LLC

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today